Cenforce (Generic Viagra)
Clinical guidance, bioequivalence criteria, and verified partner dispensing standards for Cenforce (Generic Viagra). Reviewed by board-certified internal medicine and clinical pharmacotherapy specialists.
Viagra (Generic Sildenafil) — Dosage Strengths & Online Availability
| Dosage Strength | Pack Supply | Dispensary Price | Stock Status | Verified Order |
|---|---|---|---|---|
| Viagra 25mg | Film-Coated Tablets • 30 / 60 Units | $2.04 / unit | ✓ In Stock (US Dispatch) | Select & Check Price ↗ |
| Viagra 50mg POPULAR | Film-Coated Tablets • 60 / 90 Units (Most Popular) | $1.28 / unitPOPULAR | ✓ In Stock (US Dispatch) | Select & Check Price ↗ |
| Viagra 100mg | Film-Coated Tablets • 90 / 180 Units (Best Value) | $0.68 / unitBEST VALUE | ✓ In Stock (US Dispatch) | Select & Check Price ↗ |
1. Clinical Dosing & Titration Protocols
Daily / Baseline Regimen
Not indicated for daily continuous therapy; dosed on-demand only.
On-Demand / Titration Regimen
50mg taken 45–60 minutes before intimacy. May titrate to 100mg (or Cenforce 150/200mg under clinical supervision).
Geriatric (>65) & severe renal/hepatic impairment: initiate at 25mg.
2. Patient Administration & Safe Usage Guidelines
Take on an empty stomach with a full glass of water. High-fat meals delay absorption by over an hour.
Verified Telehealth Access Standards for Cenforce (Generic Viagra)
Our clinical editorial board audits certified partner telehealth dispensaries to guarantee authentic WHO-GMP manufacturing, analytical batch testing, and physician-supervised asynchronous consultation.
Check Telehealth Protocol & Availability ↗3. Frequently Asked Patient Questions
Why should Sildenafil be taken on an empty stomach?
Dietary lipids delay gastric emptying and reduce sildenafil's peak plasma concentration (Cmax) by 29%, slowing onset.
What is Cenforce 100mg/200mg?
Cenforce is a WHO-GMP certified high-potency generic sildenafil citrate offering identical bioequivalence to brand-name Viagra.
4. Pharmacological Mechanism & Receptor Profile
Pioneering high-potency PDE5 inhibitor delivering acute penile rigidity within 30–60 minutes and lasting 4–6 hours.
Urology & Men's Health • Cenforce (Generic Viagra)
5. Chemical & Human Pharmacokinetic Matrix (Tmax, Half-Life, CYP450)
| Pharmacokinetic Parameter | Clinical Metric | Therapeutic Significance |
|---|---|---|
| Peak Plasma Time (Tmax) | 0.8 to 1.0 hour (fastest on empty stomach) | Determines latency from ingestion to peak pharmacological onset. |
| Elimination Half-Life (T½) | 3.8 to 4.0 hours | Governs duration of action and steady-state dosing intervals. |
| Peak Concentration (Cmax) | 440 ng/mL (100mg) | Maximum observed systemic concentration in human plasma. |
| Bioavailability & Food Interaction | 41% absolute bioavailability | Defines oral bioavailability and dietary lipid dependency. |
| Plasma Protein Binding | 96% | Governs free circulating drug fraction available for receptor binding. |
| Volume of Distribution (Vd) | 105 Liters | Reflects tissue and lipid compartment penetration. |
| Hepatic Metabolism | Hepatic CYP3A4 (80%) and CYP2C9 (20%) | Primary enzymatic clearance and CYP pathways. |
| Elimination / Excretion | 80% feces, 13% urine | Renal vs biliary/fecal excretion balance. |
6. Drug-Drug Interaction Matrix
| Interacting Agent / Class | Severity Tier | Clinical Mechanism & Management Strategy |
|---|---|---|
| Organic Nitrates & Riociguat | Contraindicated | Severe synergistic blood pressure drop. Minimum 24h separation. |
| Potent CYP3A4 Inhibitors | Precaution | Ritonavir increases sildenafil AUC by 11-fold; limit dose to 25mg in 48h. |
7. Adverse Reaction Profile & Clinical Incidence Rates
| Adverse Reaction | Incidence Rate | Physiological Mechanism & Mitigation Strategy |
|---|---|---|
| Facial Flushing | 18% | Peripheral arteriolar vasodilation. |
| Headache | 16% | Cranial vascular engorgement. |
| Cyanopsia (Blue Vision) | 3% | Cross-reactivity with retinal PDE6 at peak plasma concentration. |
Peer-Reviewed Scientific Citations & FDA References
- Goldstein I, et al. Oral sildenafil in erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404.
- Nichols DJ, et al. Pharmacokinetics of sildenafil citrate. Br J Clin Pharmacol. 2002;53 Suppl 1:5S-12S.